Medivolve Inc.
MEDVF
$0.00
$0.000.00%
OTC PK
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -8.11M | -9.58M | -6.36M | -11.70M | -15.10M |
| Total Depreciation and Amortization | -101.10K | -21.70K | 110.70K | 564.80K | 918.00K |
| Total Amortization of Deferred Charges | 139.70K | 139.70K | 280.00K | 280.00K | 280.00K |
| Total Other Non-Cash Items | 5.83M | 6.78M | 2.98M | 5.60M | 8.92M |
| Change in Net Operating Assets | 1.80M | 934.10K | 114.60K | 3.75M | 1.62M |
| Cash from Operations | -307.60K | -1.61M | -2.73M | -1.35M | -3.37M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -3.90K | -3.90K | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -186.90K | -186.90K | -183.00K | -183.00K | -- |
| Total Debt Issued | 0.00 | 1.20M | 1.20M | 1.20M | 1.20M |
| Total Debt Repaid | -73.80K | -1.51M | -2.22M | -2.53M | -2.52M |
| Issuance of Common Stock | -- | -- | 0.00 | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -56.00K | -232.80K | -756.40K | -993.20K | -1.63M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | -- | -- | -- |
| Net Change in Cash | -550.40K | -2.03M | -3.67M | -2.53M | -5.00M |